Zobrazeno 1 - 10
of 291
pro vyhledávání: '"Susan, King"'
Publikováno v:
The Reading Teacher, 2017 Jul 01. 71(1), 51-59.
Externí odkaz:
https://www.jstor.org/stable/26632507
Autor:
Susan King
Publikováno v:
Journal of Chemical Education. 100:243-250
Autor:
Amsal S Madhani, Susan King, Jennifer Zhu, Faisal Karmali, D Bradley Welling, Wenli Cai, Justin T Jordan, Richard F Lewis
Publikováno v:
Brain Communications. 5
Neurofibromatosis type 2–related schwannomatosis is a genetic disorder characterized by neurologic tumours, most typically vestibular schwannomas that originate on the vestibulo-cochlear nerve(s). Although vestibular symptoms can be disabling, vest
Autor:
Susan King, Kilian Dahlem, Faisal Karmali, Konstantina M. Stankovic, D. Bradley Welling, Richard F. Lewis
Publikováno v:
J Neurophysiol
Imbalance and dizziness are disabling symptoms for many patients with vestibular schwannomas (VS) but symptom severity typically does not correlate with the vestibulo-ocular reflex (VOR) amplitude-based metrics used to assess peripheral vestibular da
Publikováno v:
Otologyneurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 43(10)
To characterize visuospatial and nonvisuospatial cognitive domains affected by vestibular loss and determine whether patient-reported outcomes measures (PROMs) correlate with performance on neuropsychological tests.Cross-sectional study.University-ba
Autor:
Jared J. Hartsock, Nils Prenzler, Christina L. Runge, Thomas Lenarz, Will Mclean, Jeffrey S. Rosenbloom, Ashley S. Hinton, Steven D. Rauch, René H. Gifford, George Atiee, Alec N. Salt, Susan King, Sam Wilson, Moraye Bear, Jeffrey M. Karp, Christopher R. Loose, Jenna T.J. Herby, Carl Lebel, David L. Lucchino, Lance E. Jackson, Daniel J. Lee, Robert Langer, Athanasia Warnecke, H Schmitt
Publikováno v:
Otology & Neurotology
Objectives There are no approved pharmacologic therapies for chronic sensorineural hearing loss (SNHL). The combination of CHIR99021+valproic acid (CV, FX-322) has been shown to regenerate mammalian cochlear hair cells ex vivo. The objectives were to
Autor:
Susan King
Publikováno v:
FPID Bulletin: The Bulletin of the Faculty for People with Intellectual Disabilities. 18:11-14